IMGN Immunogen, Inc.
11,504
$31.23
$0.00
(0.00%)
| Watchers | 11,504 |
| 52-Wk Low | $3.61 |
| 52-Wk High | $31.25 |
| Market Cap | $8.72B |
| Volume | 48.61M |
| 52-Wk High | $31.25 |
| 52-Wk Low | $3.61 |
Citigroup Inc. Acquires 50,869 Shares of ImmunoGen, Inc. (NASDAQ:IMGN)Zolmax • 3 months ago
Citigroup Inc. increased its holdings in ImmunoGen, Inc. (NASDAQ:IMGN Free Report) by 26.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange...
Share to Feed
Blair William Co. IL reduced its stake in shares of ImmunoGen, Inc. (NASDAQ:IMGN Free Report) by 0.7% during the 3rd quarter, according to its most recent disclosure with the Securities...
Quantbot Technologies LP cut its holdings in ImmunoGen, Inc. (NASDAQ:IMGN Free Report) by 35.5% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 7,187 shares of the...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
AbbVie Completes Acquisition of ImmunoGen AbbVie Completes Acquisition of ImmunoGen PR Newswire NORTH CHICAGO, Ill., Feb. 12, 2024 Adds flagship antibody-drug conjugate (ADC) ELAHERE (mirvetuximab...
In a report released on February 9, Peter Lawson from Barclays maintained a Hold rating on ImmunoGen (IMGN Research Report), with a price target...
We feel now is a pretty good time to analyse ImmunoGen, Inc.'s ( NASDAQ:IMGN ) business as it appears the company may...
For the last three days, A.I.dvisor has detected that IMGN's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Research analysts at StockNews.com assumed coverage on shares of ImmunoGen (NASDAQ:IMGN Get Free Report) in a research note issued on Tuesday. The firm set a hold rating on the...
This price move could be a signal that IMGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...